Crown Biosciences, Inc. provides high quality service to support pre-clinical research and assessment of anticancer drugs. Our research staff and expert panels possess strong industrial and academic backgrounds. With our state-of-the-art laboratory facilities, validated tumor models, and supporting capabilities, we can support a complete discovery and development program for anti-cancer drugs.
We have established multiple in vitro and in vivo assay systems to evaluate novel anti-cancer compounds. Each assay is designed to understand specific aspects of drug property and its mechanism of action. By accessing our comprehensive capability, our customers can advance development programs in a timely and cost-effective manner. Our current cancer pharmacology service portfolio includes: |
